The Center for Pediatric Genomic Medicine at Children’s Mercy Kansas City is seeking ABMGG Board-Certified or Board-Eligible applicants with a PhD, MD/DO, or MD/DO/PhD to support the design and implementation of a new Cancer Genomics program. Working alongside the Director of Clinical Molecular Genetics and the Medical Director of Cancer Genomics, the incumbent will enhance the hospital and region’s capabilities in pediatric cancer treatment utilizing the latest technologies.
The successful candidate must be experienced in providing quality, timely interpretation of genome, exome, targeted panel and transriptome tests in clinical and research oncology. Candidates with experience in cancer genomics and/or candidates with Board-certification in clinical molecular genetics will be given preference. Academic appointments are available through the University of Missouri – Kansas City School of Medicine.
The individual selected for this position will
- provide guidance and analysis for both clinical and research testing
- partner with researchers throughout the hospital to design oncology translational research projects focused on the genomics of pediatric oncology and/or other specific areas of interest to the candidate
- provide interpretative consultation services focused on molecular-based oncology testing
- have the opportunity to collaborate with colleagues within The University of Kansas Cancer Center to broaden the region’s research efforts in cancer treatment in support of the Cancer Center’s NCI designation
The Center for Pediatric Genomic Medicine opened in 2011 with four staff members and now employs 19 individuals including MDs, PhDs, board-certified clinical molecular geneticists, genetic counselors, RNs, bioinformaticians, software engineers and clinical laboratory scientists experienced in genome analysis. The laboratory features six Illumina HiSeq and MiSeq sequencers and four Perkin Elmer automated workstations. The Genome team is dedicated to providing the highest quality genome testing. Our ABMGG accredited Fellowship programs in Clinical Cytogenetics and Clinical Molecular Genetics currently have two fellows in training.